आर्मेनिया -
अंग्रेज़ी -
Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
rosuvastatin denk 10mg tablets film-coated
pharmaceutical works polpharma s.a. - rosuvastatin (rosuvastatin calcium) - tablets film-coated - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
crestor 10mg tablets
astrazeneca uk ltd - rosuvastatin calcium - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
crestor 10mg tablets
waymade healthcare plc - rosuvastatin calcium - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
crestor 10mg tablets
dowelhurst ltd - rosuvastatin calcium - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
crestor 10mg tablets
de pharmaceuticals - rosuvastatin calcium - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
crestor 10mg tablets
sigma pharmaceuticals plc - rosuvastatin calcium - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
crestor 10mg tablets
mawdsley-brooks & company ltd - rosuvastatin calcium - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
crestor 10mg tablets
lexon (uk) ltd - rosuvastatin calcium - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
crestor 10mg tablets
necessity supplies ltd - rosuvastatin calcium - oral tablet - 10mg
इसराइल -
अंग्रेज़ी -
Ministry of Health
crestor 10 mg
astrazeneca (israel) ltd - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 10 mg - rosuvastatin - rosuvastatin - treatment of adults with:• primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.• homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate